Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus

Molecular and Cellular Biochemistry

Volumn 224, Issue 1-2, 2001, Pages 29-37

  Rahimian, R ^a   Masih Khan, E ^a   Lo, M ^a   Van Breemen, C ^a   McManus, B M ^a   Dube G P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adipose; Insulin resistance; Liver; Ob ob mouse; PCR; PPAR

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA1; RNA 18S; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE MODEL; GENDER; GENE OVEREXPRESSION; GENETIC ANALYSIS; IMMUNOREACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; MOLECULAR DYNAMICS; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADIPOSE TISSUE; AGING; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MUSCLE, SKELETAL; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0034796418     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011927113563     Document Type: Article

References (38)

1. Pathogenesis of insulin resistance in type 2 diabetes
2. Endocrine and metabolic effects of experimental obesity in man
3. Inducement by fat feeding of basal hyperglycemia in rats with beta cell function. Model for study of etiology and pathogenesis of NIDDM
4. Activation of member of the steroid hormone receptor superfamily by peroxisome proliferators
5. mPPARγ2: Tissue specific regulator of an adipocyte enhancer
6. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
7. Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific Mabs
8. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPARα, β and γ in the adult rat
9. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms
10. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ2 and RXRα
11. Peroxisome proliferator-activated receptor gene expression in human tissues
12. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid activated transcription factor
13. Tissue distribution and quantification of the expression of PPARs and LXRα in humans: No alterations in adipose tissue of obese and NIDDM patients
14. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor γ in human adipocytes
15. Regulation of PPARγ gene expression by nutrition and obesity in rodents
16. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptor α and γ
17. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
18. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT-4 glucose transporter expression in rat skeletal muscle
19. Thiazolidinediones improve hepatic insulin resistance in streptozotocin induced diabetic rats
20. Thiazolidinediones produce conformational changes in peroxisomal proliferator-activated receptor γ: Binding and activation correlate with antidiabetic actions in db/db mice
21. The structure activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones
22. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
23. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
24. Organization, promoter analysis and expression of the human PPARγ gene
25. Skeletal muscle peroxisome proliferator-activated receptor γ expression in obesity and non-insulin dependent diabetes mellitus
26. PPARγ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
27. Troglitazone effects on muscle gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator receptor γ
28. Rosiglitazone (BRL 49653), a PPARγ-selective agonist, causes peroxisome proliferator-like effects in obese mice
29. Leptin and its receptors: Regulators of whole-body energy homeostasis
30. Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus
31. A simple measure of insulin resistance
32. Cytosolic and nuclear distribution of PPARγ2 in differentiating 3T3-L1 preadipocytes
33. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: Relation to insulin action
34. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X-receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients
35. Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression
36. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
37. Pioglitazone induced in vivo adipocyte differentiation in the obese Zucker fa/fa rat